Budget Amount *help |
¥45,110,000 (Direct Cost: ¥34,700,000、Indirect Cost: ¥10,410,000)
Fiscal Year 2020: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
Fiscal Year 2019: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
Fiscal Year 2018: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
Fiscal Year 2017: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
Fiscal Year 2016: ¥9,750,000 (Direct Cost: ¥7,500,000、Indirect Cost: ¥2,250,000)
|
Outline of Final Research Achievements |
Cancer cells receive signals from surrounding stromal cells in vivo, and conversely, the cancer cells themselves induce stromal cells suitable for survival. In this study, based on the mouse / human-derived sequence separation method developed by the applicant so far, the global view and diversity of cancer-stromal interactions in Xenograft of various cancer types, including PDX, was analyzed at the genomic level. We also developed interactome analysis methods among different cell types from the single cell transcriptome data, and analyzed cancer tissues homeostatic microenvironment. As a result, we were able to find and experimentally verify new important molecules responsible for cancer-stromal interactions in several cancer types.
|